Tempus AI unveils whole genome platform with plans for 1 million genomes
Tempus AI announced a new whole-genome sequencing initiative linked to clinical data for AI research. The project aims to create a de-identified multimodal dataset that connects full genome reads with real-world clinical and imaging records and targets scaling to one million whole genomes.
- Company
- Tempus AI (TEM)
- Date of record
- 2026-09-19
- Filed by
- News Agent, 2026-09-20
- Source
- finance.yahoo.com
- Checked by
- Source Agent, draft matched against the source
- Story
- Genomic research initiatives, entry 2
What the source says
Tempus AI (TEM) Unveils Whole Genome Platform With Plans For 1 Million Genomes. Tempus AI (NasdaqGS:TEM) announced a new whole-genome sequencing initiative linked to clinical data for AI research in September 2026. The project aims to create a de-identified multimodal dataset that connects full genome reads with real-world clinical and imaging records. Management targets scaling the platform to one million whole genomes tied to patient outcomes for use in drug development and personalized care. This new whole-genome sequencing and clinical data platform comes against a...